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Unassembled immunoglobulin light chains expressed by the mouse plasmacytoma cell line NS1
(kNS1) are degraded in vivo with a half-life of 50–60 min in a way that closely resembles
endoplasmic reticulum (ER)-associated degradation (Knittler et al., 1995). Here we show that the
peptide aldehydes MG132 and PS1 and the specific proteasome inhibitor lactacystin effectively
increased the half-life of kNS1, arguing for a proteasome-mediated degradation pathway. Subcel-
lular fractionation and protease protection assays have indicated an ER localization of kNS1 upon
proteasome inhibition. This was independently confirmed by the analysis of the folding state of
kNS1 and size fractionation experiments showing that the immunoglobulin light chain remained
bound to the ER chaperone BiP when the activity of the proteasome was blocked. Moreover,
kinetic studies performed in lactacystin-treated cells revealed a time-dependent increase in the
physical stability of the BiP–kNS1 complex, suggesting that additional proteins are present in the
older complex. Together, our data support a model for ER-associated degradation in which both
the release of a soluble nonglycosylated protein from BiP and its retrotranslocation out of the ER
are tightly coupled with proteasome activity.
INTRODUCTION
Folding and assembly of many cellular and extracellular pro-
teins occur in the endoplasmic reticulum (ER). Molecular ER
chaperones are believed to monitor both processes, ensuring
that only when they are completed are proteins allowed to exit
the ER and to follow the secretory pathway to their final
destination. As an integral part of such a quality control system
(Hammond and Helenius, 1995; Leitzgen and Haas, 1998),
polypeptides that fail either to fold or to assemble correctly
are retained in the ER by the chaperones and are eventually
degraded. This process is called ER-associated degradation
(ERAD) because it usually is rapid and nonlysosomal and
occurs in a pre-Golgi compartment (Brodsky and McCracken,
1997; Sommer and Wolf, 1997). A growing number of ERAD
substrates have been identified, among them a mutant form
of carboxypeptidase Y (CPY*), unglycosylated prepro-a-factor,
a1-antitrypsin, unassembled T-cell receptor (TCR) subunits,
unassembled major histocompatibility complex (MHC) class I
heavy chain, mutant ribophorin, and the cystic fibrosis trans-
membrane conductance regulator (Jensen et al., 1995; Ward et
al., 1995; Knop et al., 1996a; McCracken and Brodsky, 1996; Qu
et al., 1996; Hughes et al., 1997; Huppa and Ploegh, 1997; Yu et
al., 1997; deVirgilio et al., 1998).
In a remarkable convergency of mammalian cell biology
and yeast genetics, many components of the ERAD machin-
ery have been uncovered (Hampton et al., 1996; Wiertz et al.,
1996b; Plemper et al., 1997). The current model proposes that
ERAD substrates are retrotranslocated from the ER to the
cytosol via the Sec61 protein channel for degradation by the
proteasome (Wiertz et al., 1996a; Kopito, 1997; Pilon et al.,
1997). In many cases, the degradation is ubiquitin dependent
(Hiller et al., 1996; Biederer et al., 1997; deVirgilio et al., 1998).
The ER chaperones Kar2p (the yeast homologue of BiP) and
calnexin and the DnaJ homologue Sec63p seem also to be
involved, at least for some substrates (Qu et al., 1996; Plem-
per et al., 1997). Other genes, to be characterized, have been
discovered in two independent genetic screens for mutants
with impaired ERAD (DER and HERD genes; Hampton et
al., 1996; Bordallo et al., 1998). However, despite the rapid
increase in the knowledge of the ERAD machinery, much
less is clear about the precise mechanistic roles of its com-
ponents. Noteworthy, the delivery steps to the retrotranslo-
cation channel and the driving force for this backward
movement are still unresolved issues. Obvious candidates
for the delivery are ER chaperones, in particular calnexin
(see Qu et al., 1996; Liu et al., 1997), and possibly some of the
DER and HERD genes, but no conclusive data are available.
From genetic studies in yeast, cytosolic hsp70s have been
eliminated as ERAD players (Brodsky et al., 1999), and some
suggestive results have been reported in the case of integral
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membrane proteins, pointing to the proteasome itself as the
driving force for retrotranslocation (Mayer et al., 1998; Plem-
per et al., 1998).
We are specially interested in the role of BiP in ERAD. For
this purpose, we are using the immunoglobulin (Ig) light (L)
chain kNS1, a soluble and unglycosylated polypeptide syn-
thesized by NS1 plasmacytoma cells, as a model protein. It
represents a particularly suitable model for analyzing the
role of BiP in degradation, because unassembled kNS1 is
quantitatively bound to BiP in a 1:1 complex, and its half-life
nicely correlates with the rate of BiP–kNS1 complex dissoci-
ation when kNS1 is expressed in the absence of Ig heavy (H)
chains (Knittler and Haas, 1992; Knittler et al., 1995; Cremer
et al., 1994). This Ig L chain is a natural substrate, because it
completely folds and is secreted when allowed to assemble
into antibody molecules. Furthermore, the BiP binding site
has been mapped to the unfolded N-terminal variable do-
main of this as well as of another unassembled Ig L chain,
whereas the C-terminal constant domain is folded and not
bound to BiP (Skowronek et al., 1998; Hellman et al., 1999).
The half-lifes of different unassembled Ig L chains have been
correlated with their variable domains (Skowronek et al.,
1998), suggesting an important role for BiP in the degrada-
tion of these molecules.
In this study, we have analyzed by using different meth-
ods the fate of kNS1 in NS1 cells after proteasome inhibition.
Our findings strongly support a model in which dissociation
of kNS1 from BiP immediately precedes backward move-
ment of the unglycosylated protein out of the ER lumen.
Proteasome activity is required for retrotranslocation, either
for the movement through the retrotranslocation channel or
for the dissociation of the BiP–Ig L chain complex or for both
steps.
MATERIALS AND METHODS
Chemicals and Antibodies
Chemicals were obtained from Sigma (St. Louis, MO), except
MG132 and lactacystin, which were purchased from Calbiochem
(La Jolla, CA), and the gel filtration molecular weight standards,
from Amersham Pharmacia Biotech (Uppsala, Sweden). PS1 was a
kind gift from P. Kloetzel (Humboldt University, Berlin, Germany).
Affinity-purified goat antibodies to mouse k Ig L chains were from
Southern Biotechnologies (Birmingham, AL); polyclonal anti-Grp78
(PA1–014) and anti-calreticulin antibodies (PA3–900) were from
Affinity Bioreagents (Golden, CO); the rabbit anti-rodent BiP anti-
serum was a kind gift from L. Hendershot (St. Jude Children’s
Research Hospital, Memphis, TN). Anti-tubulin monoclonal anti-
body was a kind gift from J. Wehland (Gesellschaft fu¨r Biotechnolo-
gische Forschung, Braunschweig, Germany) (Wehland and Weber,
1987), and anti-calnexin antiserum was a kind gift from E. Ivessa
(University and Biocenter, Vienna, Austria) (deVirgilio et al., 1998).
Cell Culture
NS1 is a murine plasmacytoma, which synthesizes but does not
secrete Ig L chains of the k isotype (Ko¨hler et al., 1976). The cells
were routinely maintained in RPMI 1640 medium supplemented
with 10% FCS, 1000 U/ml penicillin, and 1 mg/ml streptomycin.
Biosynthetic Labeling, Immunoprecipitation, and
Western Blot Analysis
Cells (2 3 106cells/ml) were starved for 2 h in methionine-free
RPMI 1640 medium containing 10% dialyzed FCS before [35S]Met
was added for 30 min (120 mCi/ml). The chase was initiated by
addition of excess unlabeled methionine (2 mM). Aliquots were
removed at various times of chase, and cells were separated from
supernatants and washed once with ice-cold PBS before lysis in
NET buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH 7.4, 0.5%
NP-40) (Kessler, 1975) in a final concentration of 2 3 106 cells/ml.
After 30 min of solubilization, a postnuclear supernatant was ob-
tained by 10 min of 10,000 3 g centrifugation at 4°C. Inhibitors (25
mM lactacystin, 50 mM MG132, and 60 mM PS1) and DMSO as a
control were included from the beginning of the starving period to
the end of the chase, except for MG132, which was added immedi-
ately after the chase was initiated. In some experiments N-ethylma-
leimide (NEM; 20 mM) was included in the PBS wash and in the
lysis buffer to prevent postlysis oxidation of free sulfhydryl groups
and allowing monitoring of the folding state of the Ig L chains.
Immunoprecipitations were performed from equivalent amounts
of cell lysates by adding an equal volume of immunoabsorbent
buffer (200 mM H3BO3, 50 mM Na2B4O7, 150 mM NaCl, 1% NP-40,
and 0.1% ovalbumin, pH 8.3) and polyclonal antibodies to BiP or
goat antibodies to mouse Ig L chains, in combination with protein
A-Sepharose. Precipitates were washed four times with borate-NaCl
buffer (0.5% NP-40, 1 M NaCl, 25 mM Na2B4O7, and 0.1 M H3BO4,
pH 8.3) and twice with 40 mM HEPES, pH 8. Samples were run on
SDS-PAGE under reducing or nonreducing conditions. Gels were
stained with Coomassie brilliant blue to control for precipitating
antibodies, the labeled proteins were visualized by autoradiogra-
phy, and Ig L chain and BiP bands were quantified with a phos-
phorimager (Fujix [Tokyo, Japan] BAS1000 using the program
MACBAS version 1.0).
For Western blotting, proteins from equivalent amounts of either
lysate or the different subcellular fractions (see below) were sepa-
rated by SDS-PAGE and transferred onto nitrocellulose membranes
that were blocked in PBS, 0.5% dry milk powder, and 0.05% Tween
20. Subsequently, the membranes were incubated with the follow-
ing dilutions of antibodies: 1:500 for anti-k, 1:1000 for anti-BiP
(PA1-014), 1:5000 for anti-calnexin, 1:2000 for anti-tubulin, and
1:1000 for anti-calreticulin. Proteins were visualized, after incubat-
ing with the corresponding HRP-conjugated secondary antibodies,
with the ECL chemiluminiscence blotting substrate (Boehringer
Mannheim, Mannheim, Germany). Signals from Western blot were
quantified by standard scanning densitometry using the NIH Image
program.
Subcellular Fractionation
Cells were labeled as stated above and chased for 3 h in the presence
or absence of lactacystin. Cells (1.4 3 107) were washed with PBS
and gently resuspended in an isotonic buffer (250 mM sucrose, 10
mM triethanolamine, and 1 mM EDTA, pH 7.4). Homogenization
was performed by passing the cells 10 times through a 25-gauge
needle and six times through a 27-gauge needle. Unbroken cells and
debris were removed by two consecutive 1000 3 g centrifugations
(10 min, 4°C). The supernatant was pelleted again by centrifugation
at 100,000 3 g (90 min, 4°C), and the membrane vesicles (P3) and the
cytosolic fraction (SN) were obtained. Proteins from equivalent
amounts of the different fractions were used for immunoprecipita-
tions or for Western blot.
Trypsin Protection Assays
The vesicle fraction (P3) obtained from the subcellular fractionation
was resuspended in the isotonic buffer and incubated for 30 min at
30°C in the absence or presence of 15 mg/ml trypsin. Another
aliquot of the fraction was incubated similarly in parallel in the
presence of trypsin and 0.5% NP-40. Trypsin digestions were
stopped by the addition of 500 mg/ml trypsin inhibitor. The differ-
ent samples were used for either immunoprecipitation or Western
blot.
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Size Fractionation
Cells were biosynthetically labeled as above and chased for 3 h in
the absence or presence of lactacystin. Lysates were obtained at a
concentration of 107 cells/ml in NET buffer. Gel filtration was
performed on a SMART system using a Superdex 200 column
(Amersham Pharmacia Biotech) with a constant flow of 40 ml/min
at 8°C. Fractions (50 ml) eluting from the column were used for
immunoprecipitation assays performed with anti-k antibodies.
RESULTS
Ig L Chains kNS1 Are Degraded by the Proteasome
Previous studies from our laboratory (Knittler and Haas,
1992; Knittler et al., 1995) and the laboratory of Y. Argon
(Gardner et al., 1993) showed that in the absence of Ig H
chain expression, some Ig L chains are not secreted but
degraded in vivo. This degradation occurs in a pre-Golgi
compartment and is not inhibited by lysosomotropic agents.
These features are shared by a growing number of proteins
recently shown to be degraded in a proteasome-dependent
manner (Ivessa et al., 1999). We set out to determine whether
the unassembled Ig L chains were degraded by the protea-
some by performing pulse–chase experiments in NS1 cells
followed by anti-k immunoprecipitations (Figure 1). As pre-
viously described, the half-life of kNS1 was ;1 h in untreated
cells. In the presence of the proteasome inhibitors PS1,
MG132, and lactacystin, an increase in the half-life of kNS1
was observed varying from two- to fivefold depending on
the experiment and/or the inhibitor used. However, there
was no increase in the amount of secreted Ig L chains; we
found ,5% in 4 h of chase in control as well as inhibitor-
treated cells (our unpublished data), suggesting that the
kNS1 chains were still degradation targets. This was con-
firmed by experiments in which the inhibitor MG132 was
washed away after 4 h of chase: under these conditions
degradation of kNS1 parlayed (our unpublished results).
Thus, the data indicated that, as expected, kNS1 degradation
was mediated by the proteasome, implying that the Ig L
chain must be retrotranslocated to the cytosol where the
proteasome resides (Enenkel et al., 1998; Rivett, 1998). All
further experiments were performed with lactacystin be-
cause of its higher specificity for proteasome inhibition
(Fenteany and Schreiber, 1998; Lee and Goldberg, 1998).
Unassembled Ig L chains occur as partially folded BiP-
bound molecules in the cell, and BiP binds to the N-terminal
variable domain in which the intrachain disulfide bond is
not formed. The intrachain disulfide bond is formed in the
C-terminal constant domain, which does not bind to BiP
(Skowronek et al., 1998; Hellman et al., 1999). Under nonre-
ducing conditions, immunoprecipitated kNS1 chains are
found in two forms in control cells (Figure 2; Knittler et al.,
1995): a partially oxidized form (I; reflecting a molecule with
an oxidized constant domain and a reduced, BiP-bound
variable domain) and a completely oxidized form (II) most
probably a product of postlysis oxidation of the variable
domain after dissociation from BiP during immunoprecipi-
tation. We reasoned that an indirect measure of the localiza-
tion to the ER lumen of the Ig L chain (as BiP-bound kNS1)
would be the presence of form I. A pulse–chase experiment
was performed in which the cells were lysed in the presence
of the alkylating agent NEM. The folding state and the
relative amounts of the two forms during the chase were
similar in control and proteasome-inhibited cells (Figure 2).
Some investigators have reported the detection of com-
pletely reduced molecules upon inhibition of their degrada-
tion (Tortorella et al., 1998). We did not detect any reduced
Ig L chains (which should be visible as a slower migrating
band above the partially oxidized form) even with longer
exposures of the autoradiogram shown in Figure 2 or by
Western blotting of overloaded gels. To rule out the possi-
blity that we failed to detect reduced molecules because the
antibodies used would not bind to an Ig L chain with a
reduced constant domain, we tested the antibodies for their
capacity to immunoprecipitate reduced kNS1 chains. In com-
parison with partially folded Ig L chains, 40–50% of the
molecules could still be immunoprecipitated when com-
Figure 1. Effect of proteasome inhibitors on the half-life of Ig LkNS1
chains. A representative pulse–chase experiment is shown. NS1
cells were starved for 2 h in the presence of lactacystin or PS1,
labeled for 30 min, and chased up to 4 h in the continuous presence
of the inhibitors. MG132 was added after the pulse, because we
observed a decrease in protein synthesis when it was present from
the beginning of the experiment. At each of the time points indi-
cated, postnuclear supernatant was prepared from equal numbers
of cells (with the same incorporation of radiactivity) and used to
immunoprecipitate the kNS1 chains as stated in MATERIALS AND
METHODS. The calculated half-lifes in minutes are indicated.
Figure 2. Folding state of IgkNS1 chains upon lactacystin treat-
ment. A pulse–chase experiment similar to that shown in Figure 1
was performed, with the following modifications: before lysis, cells
were washed 5 min with PBS in the presence of 20 mM NEM, and
the same NEM concentration was included during lysis. Ig L chains
were immunoprecipitated under the usual conditions (see MATE-
RIALS AND METHODS). SDS-PAGE was performed under nonre-
ducing conditions, which allows distinction of two different folding
forms of the kNS1 chains (I, partially oxidized; and II, completely
oxidized).
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pletely reduced (our unpublished data). Thus, these results
show that the vast majority of the kNS1 chains prevented
from degradation remain in a partially folded state pointing
to an ER localization of BiP-bound kNS1 in proteasome-
inhibited cells.
Ig L Chains Remain in the ER Lumen When
Proteasome Activity Is Inhibited
We addressed ER localization of kNS1 chains after lactacystin
treatment more directly by cell fractionation and protease
protection assays. To this end, NS1 cells were labeled for 30
min and chased for 3 h in the presence or absence of lacta-
cystin. Cells were mechanically homogenized in isotonic
buffer and fractionated by differential centrifugation. Ig L
chains were immunoprecipitated from equivalent amounts
of solubilized fractionated or unfractionated material and
separated by SDS-PAGE, and the signals were quantified
(Figure 3 and Table 1). The higher amount of labeled Ig L
chains recovered from lactacystin-treated cells reflects the
extent of proteasome inhibition (Figure 3, compare lanes 1
and 6, respectively), because the same amount of total ra-
diolabeled proteins from control or lactacystin-treated cells
was used for immunoprecipitations. Nevertheless, there was
no significant difference in the relative amounts of kNS1
chains recovered from the various fractions when both con-
ditions were compared (Figure 3, compare lanes 2–5 with
lanes 7–10). We repeatedly detected kNS1 in the cytosolic
fraction (SN), most likely a result of ER membrane leakage,
because a part of other soluble ER markers such as BiP or
calreticulin was also found in that fraction (Figure 3, lanes 5
and 10). The vesicle fraction P3 contained little or no cyto-
solic contaminants, as indicated by the absence of detectable
cytosolic marker tubulin (our unpublished data). Quantifi-
cation of the signals obtained showed the relative distribu-
tion of kNS1 in the vesicle (P3) and cytosolic (SN) fractions
obtained from cells treated with or without lactacystin (Ta-
ble 1). Based on the extent of inhibition, we calculated the
values expected for a situation in which all kNS1 molecules
accumulating in lactacystin-treated cells had been translo-
cated to the cytosol (Table 1). From these results, we con-
clude that kNS1 chains are not translocated to the cytosol but
remain associated with ER membranes after proteasome
inhibition.
The fractionation data did not exclude that at least some
of the Ig L chains were located at the cytosolic face of the
ER membrane, as has been reported for other proteins in
similar conditions (Hiller et al., 1996; Meerovitch et al.,
1998). To control for this possibility, trypsin protease
protection experiments were performed with the vesicle
fraction P3 (Figure 4A). Ig L chains were then immuno-
precipitated and quantified, and general leakage of solu-
ble proteins from the lumen of the vesicles was monitored
by Western blot of calreticulin, a soluble ER chaperone.
Under optimal conditions, one would expect to find cal-
reticulin completely protected from trypsin digestion on
the one hand, whereas both calreticulin and the Ig L
chains should be completely degraded upon detergent
treatment, on the other hand. We never achieved such a
condition, even when we used BiP as a lumenal marker or
proteinase K instead of trypsin (our unpublished data).
Regardless of these technical difficulties, however, the
protection of Ig L chains from trypsin digestion was the
same in control and lactacystin-treated samples and did
not significantly differ from that found for calreticulin
Figure 3. Localization of Ig LkNS1 chains by cell fractionation. NS1
cells were starved, labeled, and chased for 3 h in the presence or
absence or lactacystin (the amounts of kNS1 just after the pulse were
the same in both conditions). Cells were mechanically homoge-
nized, and the different fractions (P1, P2, P3, and SN) were obtained
by differential centrifugation as indicated in MATERIALS AND
METHODS. H corresponds to unfractionated material. Equivalent
amounts of the fractions were used to immunoprecipitate BiP or
kNS1 or to detect calreticulin by Western blotting. The signals from
the immunoprecipitates were quantified by phosphorimager, and
the Western blot signals were quantified by scanning densitometry
using the NIH Image program. Note that the Ig L chains were
stabilized by a factor of 6.4–8 (mean, 7.5) in three independent
experiments, only one of which is shown.
Table 1. Ig L chain localization after proteasome inhibition
Actual valuesa Theoretical valuesb
P3 SN P3 SN
DMSO 72.2 6 3 27.8 6 3 100 0
Lactacystin 65 6 2 35 6 2 14.1 6 1.3 85.9 6 1.3
a Signals of labeled k chains immunoprecipitated from equivalent
amounts of the vesicular fraction (P3) and the cytosol (SN) prepared
from lactacystin-treated or control (DMSO) cells as described in the
legend to Figure 3 were quantified by phosphorimaging. For each of
the three independent experiments and conditions, the total amount
of k chains (P3 1 SN) was set to 100%, and the percentage of k
chains present in P3 (%P3 5 P3/(P3 1 SN) and in SN (%SN 5 1 2
%P3) was determined.
b Theoretical values were deduced from the data of the three pulse–
chase experiments (with or without lactacystin) used for the frac-
tionations. The amount of k chains after 3-h lactacystin treatment
minus the amount of k chains in the respective control represented
the amount of nondegraded chains accumulated after 3 h of chase.
This value, given as a percentage of the total amount of k chains at
3 h of chase (plus lactacystin), represented the fraction of chains
expected to be in the cytosol (SN) if retrotranslocation was not
coupled to proteasome activity. In the control, these theoretical
values were set to P3 5 100 and SN 5 0, because these are the values
most approximated to the situation in vivo.
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(Figure 4B), arguing for a lumenal accumulation of Ig L
chains prevented from degradation.
Ig L Chain Is Quantitatively Bound to BiP in
Lactacystin-treated Cells
An independent way to study localization of Ig L chains is to
determine whether the molecules are bound to the luminal ER
chaperone BiP, as was already demonstrated for kNS1 in un-
treated cells (Knittler et al., 1995). For this purpose, size frac-
tionation experiments were performed. Samples were applied
onto a Superdex 200 column, and eluted fractions were used to
immunoprecipitate kNS1. Under control conditions, the BiP–
kNS1 complex is well preserved as the Ig L chains were recov-
ered in fractions corresponding to the expected molecular mass
of a stochiometric BiP–kNS1 complex, and no other major peak
appeared (Figure 5A). From the gels used to quantify the
relative amount of Ig L chains, it is seen that BiP coprecipitated
with kNS1 chains in these fractions (Figure 5B). In the presence
of MgATP that leads to dissociation of BiP–ligand complexes,
the Ig L chains were recovered in fractions corresponding to
monomeric molecules (Knittler et al., 1995; our unpublished
data). We repeated the experiment in parallel with samples
chased for 3 h in the presence of lactacystin. The eluting profile
of Ig L chain was undistinguishable from that of the control
sample (Figure 5A), and MgATP caused the same effect as in
the control.
Figure 4. Trypsin resistance of kNS1 chains. (A) Equal amounts of
the P3 fractions prepared from untreated and lactacystin-treated
cells were treated with 15 mg/ml trypsin for 30 min at 30°C in the
absence or presence of 0.5% NP-40. Digestions were stopped by the
addition of 500 mg/ml trypsin inhibitor. Samples were used for
either immunoprecipitation of Ig L chains or proving the amount of
calreticulin by Western blot. (B) Ig L chain signals were quantified
by phosphorimager, calreticulin signals were quantified by scan-
ning densitometry, and the values were plotted as the percentage of
the amount of the respective protein present in the corresponding
untreated samples. Note that no calreticulin signals could be de-
tected after trypsin digestion of NP-40-solubilized material.
Figure 5. Size fractionation of kNS1 chains. NS1 cells were starved, la-
beled, and chased for 3 h in the presence or absence of lactacystin. For
solubilization, cell concentrations were adjusted to 107cells/ml of NET
buffer. Fifty microliters of sample were applied onto a Superdex 200
column (SMART system), and proteins were separated at a flow rate of 40
ml/min. Fractions of 50 ml were collected and used to immunoprecipitate
the Ig L chains that were analyzed by SDS-PAGE under reducing condi-
tions. (A) The signals were quantified by phosphorimager, and the
amount of Ig L chains present in each fraction was plotted as the percent-
age of total Ig L chains present in the load. The molecular mass standarts
used were ferritin (440 kDa), aldolase (158 kDa), BSA (60 kDa), and
carbonic anhydrase (30 kDa). (B) The autoradiograms of the gels used to
quantify the Ig L chain signals (fraction 15–25) are shown. Note that the
signals for coprecipitated BiP parallels the Ig L chain distribution.
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The combination of the results presented in Figures 3–5
indicated that, even after proteasome inhibition, kNS1 chains
were quantitatively bound to BiP in a partially oxidized
form. As a consequence, these results independently con-
firmed that kNS1 was localized in the ER when degradation
was blocked, despite the cytosolic location of the protea-
some. An important corollary of this is that the retrotrans-
location of the Ig L chains is tightly coupled with the cata-
lytic activity of the proteasome itself.
Proteasome Inhibition Increases the Physical
Stability of the BiP–kNS1 Complex
Unassembled Ig L chains are quantitatively bound to BiP in
a 1:1 complex in vivo (Cremer et al., 1994; Knittler et al., 1995;
Figure 5). Moreover, the dissociation kinetics of kNS1 from
BiP matches the half-life of the Ig L chain itself (Knittler and
Haas, 1992) pointing to an important function of BiP in the
degradation of unassembled Ig L chains. We followed the
fate of the BiP–kNS1 complex in the absence or presence of
lactacystin by coimmunoprecipitation experiments. BiP and
coimmunoprecipitated kNS1 chains were visualized in the
same gel (no second immunoprecipitation is necessary, be-
cause the Ig L chain is the major BiP substrate in NS1 cells;
Figure 6A). In the control situation, only a small portion
(2–5%) of the kNS1 chains present in the sample was coim-
munoprecipitated with BiP. This was partly due to incom-
plete immunoprecipitation of BiP. In fact, only 30–40% of
the total amount of BiP was isolated in these experiments. In
addition, the V domain of the kNS1 does not exhibit a very
stable interaction with BiP during immunoprecipitation, in
contrast to BiP–IgL chain complexes seen with size chroma-
tography (Figure 5; Knittler and Haas, 1992; Skowronek et
al., 1998). Nevertheless, and as expected, the kinetics of kNS1
dissociation from BiP was identical to that of kNS1 degrada-
tion (Figure 6, A and B). In contrast, the dissociation of kNS1
from BiP did not match the half-life of kNS1 when the pro-
teasome inhibitor was present (Figure 6, A and B). Instead,
the Ig L chain signal remained constant or even slightly
increased during the chase, depending on the experiment.
The coimmunoprecipitation of Ig L chains with BiP was
specific, as it was abolished by treatment with MgATP be-
fore immunoprecipitation (our unpublished data). We quan-
tified the Ig L chain signals to determine the percentage of
coprecipitated kNS1 and consistently found a two- to three-
fold increase after 2 h of chase when lactacystin was present
(Figure 6C).
These results were surprising. Certainly, the presence of
the proteasome inhibitor should lead to a net increase in the
amount of total Ig L chains. But even if this caused the
formation of additional BiP–kNS1 complex during the chase,
one would not expect to find increasing levels of labeled Ig
L chains coprecipitating with BiP, because elevated levels of
kNS1 would decrease the specific activity in the total Ig L
chain pool to the same extent. Therefore, a shift in the
equilibrium toward the BiP–kNS1 complex recovered by im-
munoprecipitation of BiP could at most be due to an increase
in the total amount of BiP, which could escape our analysis
because additional BiP would not be labeled. Indeed, it has
been reported that proteasome inhibition leads to up-regu-
lation of chaperones, BiP among them (Bush et al., 1997;
Mathew et al., 1998). However, we found that the total
amount of BiP remained constant in NS1 cells even after 8 h
Figure 6. Effect of lactacystin on the dissociation of kNS1 from BiP.
(A) The pulse–chase experiment was made under the same condi-
tions as in Figure 1. Equal amounts of cells were used for immuno-
precipitation of either Ig L chains or BiP. The calculated half-lives
and dissociation rates in minutes are shown for comparison. Note
that no dissociation rate can be calculated when lactacystin is
added. A reprentative experiment is shown. (B) Ig L chain signals
were quantified from the above-shown autoradiograms, and the
signals at chase point 0 were set to 100. Note that the two curves
obtained for kNS1 chains in the presence of lactacystin differ, de-
pending on whether the Ig L chains were directly precipitated or
coprecipitated with BiP. (C) The percentages of kNS1 chains copre-
cipitated with BiP were calculated at 0 and 2 h of chase. These data
represent the mean from seven independent experiments. At each
time, the value obtained at 0 h in the control situation (DMSO-0 h)
was set to 1.
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of lactacystin treatment (our unpublished data). Therefore,
the increase in the amount of BiP–kNS1 complex cannot be
explained by a simple shift in the equilibrium toward the
complex caused by an increase in the concentration of Ig L
chains or BiP. From these results, we conclude that protea-
some inhibition leads to a higher physical stability of the
BiP–kNS1 complex.
DISCUSSION
Preconditions for ERAD to occur are 1) recognition of the
misfolded protein in the ER, 2) translocation of the substrate
to the cytosol, and 3) proteasomal degradation. The first task
is most likely assumed by the various chaperones present in
the ER. An important question is whether these proteins also
assume a function in the process of substrate delivery to the
cytosol. A number of publications address the role of the
lectin-like transmembrane chaperone calnexin in the degra-
dation of misfolded glycoproteins (Knop et al., 1996b; deVir-
gilio et al., 1998; Keller et al., 1998). Genetic analysis provided
evidence for a role of the soluble chaperone BiP in the
degradation of a mutant form of the glycoprotein car-
boxypeptidase Y (Plemper et al., 1997). We have presented
here biochemical studies aimed at elucidating the role of BiP
in the degradation of a soluble unglycosylated protein using
the unassembled Ig L chain kNS1 as a model substrate. We
found that inhibition of proteasome activity led to a pro-
longed half-life of the kNS1 chains, establishing that this
protein is an ERAD substrate. Furthermore, our data indi-
cated that dissociation from BiP and retrotranslocation of the
BiP-bound substrate are tightly coupled to proteasome ac-
tivity.
As already mentioned, our previous work on Ig chains
had pointed to an important function of BiP in the rentention
in the ER and consequent degradation of unassembled mol-
ecules (Knittler and Haas, 1992; Knittler et al., 1995; Skow-
ronek et al., 1998). Similar findings were reported for a
Xenopus transmembrane protein, the P-type Na, K-ATPase.
Both the multimembrane-spanning a-subunit and the type II
transmembrane glycoprotein b subunit bind to BiP, and this
interaction correlates with the stability of the subunits when
expressed in the absence of the partner chain (Beggah et al.,
1996). All the data presented here consistently showed that
kNS1 is trapped in the ER lumen in a BiP-bound form when
proteasome activity is impaired. First, the folding state of
kNS1 chains did not change upon proteasome inhibition
(Figure 2), indicating that the Ig L chains were still bound to
BiP. In this context, it may not be too surprising that we
failed to detect Sec61p-bound Ig L chains by coimmunopre-
cipitation experiment (our unpublished data). Together,
these data argue for the Ig L chain being completely trans-
located into the ER. Moreover, one must take into account
that the second cysteine participating in the constant domain
disulfide bond is placed only 20 amino acids away from the
C terminus. In addition, it has recently been shown that
CPY* is also entirely in the ER before retrotranslocation
starts (Plemper et al., 1999). Second, subcellular fractionation
and protease digestion experiments indicated that, regard-
less of proteasome activity, Ig L chains reside within a
membrane-bounded compartment (Figures 3 and 4). Last,
size fractionation of cellular proteins revealed that Ig L
chains prevented from degradation remain in a BiP-bound
state (Figure 5). In addition, we found that degradation of
accumulated Ig L chains is resumed with the removal of a
reversible proteasome inhibitor, indicating that the condi-
tions used led to the arrest of a defined step in the normal
degradation pathway. These results also showed that the
substrate is not translocated to the cytosol in the absence of
proteasome function, strongly suggesting that extraction of
unassembled Ig L chains from the ER is concomitant with
proteolysis. The analysis of a model transmembrane protein
revealed a membrane-embedded intermediate lacking the
cytoplasmic domain when mutant proteasomes were acting
(Mayer et al., 1998). Because the special design of this model
protein may have precluded the direct extension of this
finding to other proteins, it was important to show that
proteasome activity is indeed needed for extraction of at
least some transmembrane proteins (Plemper et al., 1998), a
hypothesis also suggested by Yang et al. (1998), who showed
that TCR d is retained mostly in the ER after proteasome
inhibition.
Our data are not in contrast with other reports on retro-
translocation that occurs in the presence of proteasome in-
hibitors. A review of the literature reveals that most of the
available data support or at least do not disprove the direct
involvement of the proteasome in the retrotranslocation
event. However, a more careful quantification of fraction-
ation and protease protection experiments presented is
needed. For instance, although TCRa and mutant ribo-
phorin are partly found in the cytosol in a deglycosylated
state (Huppa and Ploegh, 1997; Yu et al., 1997; deVirgilio et
al., 1998; Yang et al., 1998), the amount detected is clearly
lower than expected given the extent of the inhibition of
degradation, as already stated by Yu and coworkers (Yu et
al., 1997). We have calculated the amount of Ig L chains
expected to be in the cytosol if retrotranslcoation had oc-
curred in the absence of proteasome function (Table 1). From
these data, it is clear that kNS1 does not leave the ER when
the proteasome is inactive. This may simply reflect that the
equilibrium between ER and soluble cytosolic forms is de-
pendent on the nature of the protein (Dusseljee et al., 1998;
Yang et al., 1998) and/or on its interaction with ER-resident
chaperones. On the other hand, the translocation pore may
be in a “closed” state (Hamman et al., 1998) and needs an
opening signal to allow an ordered process such as translo-
cation or retrotranslocation to occur. This signal could be
provided by the active proteasome.
Only the pioneering studies on cytomegalovirus protein-
induced MHC class I H chain degradation show that most of
the H chain appears in the cytosol upon expression of the
US2 and US11 proteins (Wiertz et al., 1996a,b). However, as
the same authors point out, this could just be due to an
intrinsic difference in the mechanism of retrotranslocation
induced by the viral proteins. The in vitro studies with yeast
microsomes from the laboratories of F. Brodsky, A. Mc-
Cracken, and K. Ro¨misch (Werner et al., 1996; Pilon et al.,
1997) also find significant retrograde transport of unglyco-
sylated prepro-a-factor under certain conditions, for in-
stance in the presence of mutant proteasomes. However, it is
not clear whether this reflects a particular property of the
substrate or whether the in vitro system is leaky in the
control of retrotranslocation.
ERAD seems to involve the same translocation channel as
is used for protein translocation into the ER. The yeast
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sec61-2 mutant was shown to be defective in the retrotrans-
location of ERAD substrates (Plemper et al., 1997), and the
group of H. Ploegh reported on the interaction of MHC class
I H chains with the Sec61 protein during retrotranslocation
(Wiertz et al., 1996a). Translocation of polypeptides from the
cytosol to the ER is ensured by the presence of an N-terminal
signal sequence that is cleaved off during or after transloca-
tion. One of the puzzling questions is, therefore, how lume-
nal substrates are reinserted into the translocation channel
for retrograde movement. BiP-bound substrates could be
positioned close to the translocation channel by binding of
BiP to the DnaJ-like domain of the translocon component
Sec63p (Corsi and Schekman, 1997). In fact, genetic data
support a role for Sec63p in ERAD (Plemper et al., 1999). The
existence of a human Sec63p homologue (Skowronek et al.,
1999) strongly suggests a similar function in mammalian
cells. Once the BiP–substrate complex is placed in close
proximity to the channel, one could imagine a stochastic
process for threading the polypeptide into the pore. We do
not know whether cycles of BiP binding and release occur,
but if so, the equilibrium is obviously completely shifted to
the BiP-bound state, because no free Ig L chains were de-
tected, even when proteasome activity was impaired. In fact,
recent data indicate that few, if any, cycles of binding and
release occur during the interaction of BiP with IgG H
chains, suggesting that dissociation takes place only when
the protein is either assembled with Ig L chains, if present, or
marked for degradation, if not (Hendershot, personal com-
munication). These findings could argue in favor of a signal
required to introduce the BiP-bound substrate into the trans-
location machinery. Given our results, it is tempting to spec-
ulate that active proteasome signals the triggering of the
retrotranslocation event. The group of D. Wolf has presented
data implicating BiP/Kar2p in the degradation of CPY*. The
Kar2 mutant used exhibited a defect in the ATPase domain
of the chaperone, suggesting that ATP hydrolysis is impor-
tant for release of the substrate to the cytosol. When Kar2p
function is impaired, CPY* remains in the ER (Plemper et al.,
1997). It would be interesting to know whether CPY* is
bound to Kar2p under these conditions.
As yet undefined factors, possibly DER or HERD gene
products (Hampton et al., 1996; Bordallo et al., 1998), could
be involved in the final recognition of degradation sub-
strates and their inevitable targeting to the degradative ma-
chinery by supporting threading of the substrate into the
pore and retrotranslocation. By performing kinetic studies
on BiP–kNS1 interaction in lactacystin-treated cells, we found
a time-dependent increase in the amount of labeled Ig L
chains coimmunoprecipitated with BiP (Figure 6). This
pointed to a stabilization of BiP substrate interaction, possi-
bly because of additional components participating in the
BiP–kNS1 complex before the degradation process. Although
there was no evidence for a shift in the elution profile for Ig
L chains in the presence of lactacystin (Figure 5), a higher-
molecular-weight complex composed of the BiP–kNS1 com-
plex and additional components could still exist and be
detected under different conditions. We are currently trying
to identify such putative components by different tech-
niques: high resolution size chromatography, cross-linking,
and coimmunoprecipitation with candidate proteins, but so
far all of our efforts have failed. However, one cannot dis-
card the possibility that the result of Figure 6 is due to a
conformational change in the BiP–k complex, which renders
it more stable. Anyway, in both cases, proteasome inhibition
allows the detection of a novel “state” of the BiP–k complex.
Because the arrest caused by proteasome inhibition was
reversible, we think that this stabilization reflects a transient
step in the normal degradation pathway, which became
detectable because undegraded labeled Ig L chains prepared
for retrotranslocation had accumulated.
Several models could well accommodate our data. First, a
multiprotein complex (most probably including BiP and
perhaps some DER gene products and Sec63p) could act as
the retrotranslocation apparatus, which would be allosteri-
cally connected with the proteasome to ensure a high cou-
pling between retrotranslocation and degradation. Another
possibility is that the chemical energy of ubiquitination acts
as a molecular ratchet to prevent the backward movement of
the protein once the retrotranslocation has been initiated.
Although this model seems to fit well for some proteins
(Biederer et al., 1997; deVirgilio et al. 1998), we have not
detected any trace of ubiquitination of our Ig L chains when
proteasome activity is inhibited (our unpublished results). A
more formal scenario (not yet excluded) is the existence of a
rapidly degraded inhibitor of retrotranslocation that builds
up when the proteasome is inhibited. Finally, we would like
to present our particular model for the NS1k L chain, which
is closer to the first one proposed above: kNS1 is bound to
BiP, probably together with other ER-resident proteins but
not with the Sec61 protein, in a partially folded state. BiP
molecules carrying substrate might be positioned close to
the translocation channel through binding to the Sec63 pro-
tein. Eventually, kNS1 dissociates from the complex and is
rapidly retrotranslocated to the proteasome for degradation.
Proteasome activity is required for extracting the Ig L chains
from the ER. Whereas the ATPase function of BiP could
provide a driving force from the lumenal side, the protea-
some itself, by its AAA-ATPase subunits located at the 19S
cap structure (Glickman et al., 1998; Leonhard et al., 1999),
could energize the retrotranslocation process from the outer
surface of the ER. This could be facilitated by a specific
anchoring of the proteasome to the cytosolic face of the ER
(in mammalian cells ;10% of the proteasomes are located at
that place; Rivett, 1998). It will be interesting to investigate
the role of the Sec63 protein in these processes, because with
its large cytosolic domain and the BiP-binding lumenal DnaJ
portion, it represents an ideal molecule to allow cross-talk
between the cytosolic and lumenal sides of the ER.
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